Advertisement

Topics

Human medicines European public assessment report (EPAR): Qtern, saxagliptin / dapagliflozin, Revision: 0, Authorised

10:45 EDT 27 Jul 2016 | European Medicines Agency

This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Qtern, saxagliptin / dapagliflozin, Revision: 0, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Qtern, saxagliptin / dapagliflozin, Revision: 0, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement